Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: Report of 34 cases

Journal of Clinical Oncology

Volumn 9, Issue 6, 1991, Pages 962-969

  Dini, G ^a   Lanino, E ^b   Garaventa, A ^b   Rogers, D ^b   Dallorso, S ^b   Viscoli, C ^b   Castagnola, E ^b   Manno, G ^b   Brisigotti, M ^b   Rosanda, C ^b   Pasino, M ^b   Rivabella, L ^b   Boni, L ^b   Marchese, N ^b   Ivani, G ^b   Rizzo, A ^b   Franzone, P ^b   Trasino, S ^b   De Bernardi, B ^b  

^a G GASLINI INSTITUTE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; MELPHALAN; PEPTICHEMIO; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROBLASTOMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMAN; INFANT; MALE; MIDDLE AGE; NEUROBLASTOMA; PROGNOSIS; REMISSION INDUCTION; SUPPORT, NON-U.S. GOV'T; SURVIVAL RATE; WHOLE-BODY IRRADIATION;

EID: 0025803643     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.6.962     Document Type: Article

References (13)

1. Leiken S, Evans A, Hein R: The impact of chemotherapy on advanced neuroblastoma. Survival of patients diagnosed in 1956, 1962 and 1966-68 in Children's Cancer Study Group. Am J Pediatr 84:131-134, 1974
2. Shafford EA, Rogers DW, Pritchard J: Advanced neuroblastoma: Improved response rate using a multiagent regimen (OPEC) including sequential cis-platinum and VM 26. J Clin Oncol 2:742-747, 1984
3. Dini G, Lanino E, Rogers D, et al: Resistant and relapsing neuroblastoma: Improved response rate with a new multiagent regimen (OC-HDP) including high-dose cis-platinum. Med Pediatr Oncol 15:18-23, 1987
4. Pritchard J, McElwain TJ, Graham-Pole J: High dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 45:86-94, 1982
5. August CS, Serota FT, Koch PA, et al: Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation and allogeneic or autologous marrow reconstitution. J Clin Oncol 2:609-616, 1984
6. Philip T, Bernard JL, Zucker JM, et al: High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: An unselected group of stage IV patients over 1 year of age. J Clin Oncol 5:266-271, 1987
7. Hartmann O, Benhamou E, Beaujean F, et al: Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J Clin Oncol 5:1205-1211, 1987
8. Moss TJ, Fonkalsrud EW, Feig SA, et al: Delayed surgery and bone marrow transplantation for widespread neuroblastoma. Ann Surg 206:514-520, 1987
9. Graham Pole J, Gee AP, Gross S, et al: Bone marrow transplantation (BMT) for advanced neuroblastoma (NBL): A multicentric POG pilot study, in Evans AE, D'Angio GJ, Seeger RC (eds): Advances in Neuroblastoma Research 2, Progress in Clinical and Biological Research, vol 27. Proceedings of the Fourth Symposium on Advances in Neuroblastoma Research, New York, NY, Liss, 1988, pp 215-223
10. Dini G, Lanino E, Garaventa A, et al: High-dose therapy and unpurged bone rescue for neuroblastoma with poor prognosis, in Dicke KA, Spitzer G, Jagannath S (eds): Autologous Bone Marrow Transplantation, vol 3. Proceedings of the Third International Symposium, Houston, TX, 1987, pp 393-399
11. Graham-Pole J: The role of marrow autografting in neuroblastoma. Bone Marrow Transplant 4:3, 1989
12. Seeger RC, Reynolds CP, Vo DD et al: Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads. Prog Clin Biol Res 175:443-458, 1985
13. Kemshead JT, Heath L, Gibson FM: Magnetic micro-spheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow. Experience, improvements and observations. Br J Cancer 54:771-778, 1986